Ravuconazole is a triazole compound that functions as an antifungal active pharmaceutical ingredient. It exhibits antifungal activity by inhibiting 14alpha demethylase, an enzyme involved in sterol synthesis, leading to fungal cell wall disruption and cell death.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 182760-06-1
Isavuconazole
pharmaceutical raw material
(±)-Voriconazole
pharmaceutical raw material
(2R,3S/2S,3R)-3-(4-Chloro-5-fluoro-6-pyrimidinyl)-2-(2,4-difluorophenyl)butan-2-ol
pharmaceutical raw material
Miconazole nitrate
pharmaceutical raw material
Tavaborole
pharmaceutical raw material
Tert-Butyl {(2S,3R)-4-[(4-aminobenzene-1-sulfonyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}carbamate
pharmaceutical raw material
Fenproporex hydrochloride
pharmaceutical raw material
Cabazitaxel
pharmaceutical raw material
4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile
OPAHEYNNJWPQPX-RCDICMHDSA-N
C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)O